iShares U.S. Pharmaceuticals ETF IHE

Morningstar Medalist Rating

Morningstar’s Analysis IHE

Will IHE outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares US Pharmaceuticals ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IHE

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings81.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

26.59463M
Healthcare

Johnson & Johnson

22.16386M
Healthcare

Viatris Inc

4.8584M
Healthcare

Royalty Pharma PLC Class A

4.7483M
Healthcare

Zoetis Inc Class A

4.7482M
Healthcare

Pfizer Inc

4.3175M
Healthcare

Merck & Co Inc

4.1572M
Healthcare

Bristol-Myers Squibb Co

4.0871M
Healthcare

Jazz Pharmaceuticals PLC

3.1855M
Healthcare

Elanco Animal Health Inc

2.7147M
Healthcare

Sponsor Center